Sinovac Biotech Commences SARS Vaccine Phase I Human Clinical Testing
May 24, 2004 |
Print
|
Email
|
Comments | Category: Science
Sinovac Biotech Ltd. (Sinovac) announced that it has commenced Phase I human clinical trials of its SARS vaccine.
The first subjects were injected with the vaccine on the 22nd of May 2004 at the Sino-Japan Friendship Hospital in Beijing. More details will follow in a follow-up Sinovac news release on 24th May 2004. Sinovac specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as Hepatitis A and Hepatitis B, influenza and SARS.
Related Links:
Leave A Comment:
Inside ChinaTechNews.com
-
Security
- Qihoo 360's Safebox Software Will Integrate With Uuu9.com
- Apple Suspends iPhone 4S Sales In Retail Stores In China
- New Chinese Internet Rules Focus On Data Security, Web Advertising
- Chinese Internet Users Can Report Online Fraudsters Via New Baidu Service
- Huawei To Acquire 49% Stake In Security JV With Symantec
-
Software
-
Telecom & Wireless
Visit these other China sites: ChinaRetailNews.com | GreenChinaTech.com
| ChinaWirelessNews.com
| TechSecurityChina.com
| China Sourcing News
| China CSR





